Genetron Health, Thermo Fisher to expand precision cancer diagnosis

Genetron Health and Thermo Fisher will promote NGS platforms, including Genetron S5, in the field of molecular cancer diagnosis in public hospitals across China. Credit: NIH Image Gallery.